2025 CDMO pricing data for 101 clinical and commercial microbial biologics development and manufacturing RFP service line items
Exhaustive directory of capabilities profiles for the top 44 biologics CDMOs specializing in microbial fermentation
Technical focus on the regulatory landscape and manufacturing challenges for biologics, such as GLP-1 and insulin trials, cytokines, and growth factors
Includes Nice Insight's Clinical Trials Landscape tool — an in-depth custom research platform for current and upcoming microbial biologics trials, sourced from the FDA Clinical Trials Database
Immediate access to Nice Insight's Microbial Biologics Trends & Opinions section — our SMEs' analysis of where the market is now and where it's headed.
Access to Nice Insight's Microbial Biologics Clinical Trials report, plus access to our multi-modality Clinical Trial Landscape tool — an in-depth, interactive study of current and upcoming microbial biologics trials.
Access to Nice Insight's Microbial Biologics CDMO Pricing Data from 2019-2025, including regional price breakdowns for over 100 distinct outsourcing RFP service line items.
Access to Nice Insight's Microbial Biologics CDMO Directory, including capabilities for more than 40 biologics outsourcing organizations across North America, Europe, and Asia.
Competitive Benchmarking
40+ Microbial CDMO Profiles
Clinical Trials Analysis
Biotech Funding Trends
Market Growth Projections
Manufacturing Challenges & Innovations
Over 1,000 hours of data collection and analysis —
including interviews with CDMO owners, PhDs and customers.